1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGround-Based Venous Thromboembolism (VTE) Pathophysiology and Analog is sponsored by NASA Translational Research Institute for Space Health (TRISH). Seeking innovative approaches to advance understanding of VTE pathophysiology in spaceflight and develop ground-based analogs.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Ground-Based Venous Thromboembolism (VTE) Pathophysiology and Analog Solicitation - Grant Research Integrated Dashboard Grant Research Integrated Dashboard Ground-Based Venous Thromboembolism (VTE) Pathophysiology and Analog Solicitation Opens Jun 16 2026 08:00 AM (CDT) Deadline Aug 18 2026 10:59 PM (CDT) The goal of the " Ground-Based Venous Thromboembolism (VTE) Pathophysiology and Analog Solicitation " is to advance our understanding of VTE pathophysiology i n the context of spaceflight-associated hemodynamic changes and to develop and validate ground-based analogs that replicate these conditions.
Proposals should address one of the following areas: (1) Pathophysiology studies that advance mechanistic understanding of thrombus formation under conditions of retrograde venous flow, stasis, or vessel distention relevant to spaceflight; or/and (2) Development and validation of ground-based analogs and model, including in-silico, in-vitro, ex-vivo, in-vivo , human-subject, and hybrid approaches, that reliably reproduce key in-space hemodynamic conditions and enable investigation of venous thrombus formation and progression .
Deliverables should be appropriate to the proposed area(s) of focus. Pathophysiology proposals should deliver mechanistic characterization data and analyses. Analog proposals should deliver a validated analog protocol, population variability datasets, and characterization reports.
Proposals can request up to $500K in total costs (direct + indirect costs) over a performance period of up to 15 months. Awards can begin as early as January 2027 and must be initiated by March 2027. Projects must conclude by March 31 , 2028.
Selected proposals will be funded as research grants. All categories of United States (U.S.) institutions and companies are eligible to submit proposals. Principal Investigators (PIs) may collaborate with universities, the private sector, and federal, state, and local government laboratories.
In all such arrangements, the applying entity is expected to be responsible for administering the project according to the management approach presented in the proposal. For our policy on international proposers and institutions, please refer to the FAQ and FAR Supplement .
Please see the solicitation documents below for detailed information: Frequently Asked Questions (FAQ) - Updated on 07/23/2026 VACS Instructional Document Pre-Proposal Briefing Recording (Please download the recording to enable skipping ahead within the video) Pre-Proposal Briefing Slide Deck Ground-Based Venous Thromboembolism (VTE) Pathophysiology and Analog Solicitation The goal of the " Ground-Based Venous Thromboembolism (VTE) Pathophysiology and Analog Solicitation " is to advance our understanding of VTE pathophysiology i n the context of spaceflight-associated hemodynamic changes and to develop and validate ground-based analogs that replicate these conditions.
Proposals should address one of the following areas: (1) Pathophysiology studies that advance mechanistic understanding of thrombus formation under conditions of retrograde venous flow, stasis, or vessel distention relevant to spaceflight; or/and (2) Development and validation of ground-based analogs and model, including in-silico, in-vitro, ex-vivo, in-vivo , human-subject, and hybrid approaches, that reliably reproduce key in-space hemodynamic conditions and enable investigation of venous thrombus formation and progression .
Deliverables should be appropriate to the proposed area(s) of focus. Pathophysiology proposals should deliver mechanistic characterization data and analyses. Analog proposals should deliver a validated analog protocol, population variability datasets, and characterization reports.
Proposals can request up to $500K in total costs (direct + indirect costs) over a performance period of up to 15 months. Awards can begin as early as January 2027 and must be initiated by March 2027. Projects must conclude by March 31 , 2028.
Selected proposals will be funded as research grants. All categories of United States (U.S.) institutions and companies are eligible to submit proposals. Principal Investigators (PIs) may collaborate with universities, the private sector, and federal, state, and local government laboratories.
In all such arrangements, the applying entity is expected to be responsible for administering the project according to the management approach presented in the proposal. For our policy on international proposers and institutions, please refer to the FAQ and FAR Supplement .
Please see the solicitation documents below for detailed information: Frequently Asked Questions (FAQ) - Updated on 07/23/2026 VACS Instructional Document Pre-Proposal Briefing Recording (Please download the recording to enable skipping ahead within the video) Pre-Proposal Briefing Slide Deck Jun 16 2026 08:00 AM (CDT) Aug 18 2026 10:59 PM (CDT)
According to the current listing, eligibility includes: U. S. -based institutions, commercial entities, and other research organizations. Confirm the full requirements in the official notice before applying.
The current listing shows up to $500,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 18, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Ground-Based Venous Thromboembolism (VTE) Pathophysiology and Analog is funded by NASA Translational Research Institute for Space Health (TRISH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NASA published an RFI on September 12, 2026 seeking states willing to host and sponsor the new United States Space Academy, with responses due October 26 at 6 p.m. EDT through SAM.gov. Only a governor or a governor's designee may submit, and only once per state. The timeline demands groundbreaking by 2027, 300 students in temporary facilities in 2028, and a permanent campus by 2031. Here is what that structure actually means for universities, economic development agencies, and contractors in the states that compete.
Read articleNASA funds SBIR proposals in propulsion, in-space manufacturing, life support, autonomy, and Earth observation. Here are the topic areas and how to position for the 2026 restart.
Read articleThe most bipartisan space bill in years creates new commercial research programs, codifies lunar outpost goals, and opens pathways for researchers who have never worked with NASA.
Read article